Catalyst Wire Dossier Catalyst Wire Dossier

pomalidomide-dexamethasone

pomalidomide-dexamethasone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for pomalidomide-dexamethasone, covering 2022-07-27 to 2022-07-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide [Phase 3]

See pricing